# Elucid Bioimaging, Inc.

- Location (FDA's records): Boston, MA
- FDA decisions: 6 (2017–2026): 6 510(k) clearances
- Product codes: LLZ (5), PJA (1)
- 510(k) review time since 2016: median 106 days, against 110 for FDA's reviews in the same codes and years (4 of 5 faster)
- Predicates its devices cite: 6 (2 its own); citations of its devices by later devices: 3 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Object Research Systems (Ors), Inc.: 2 (https://510kreport.com/company/object-research-systems-ors)
- Vital Images, Inc.: 1 (https://510kreport.com/company/vital-images)
- HeartFlow, Inc.: 1 (https://510kreport.com/company/heartflow)

## Firms that cite its devices most
- Navier Medical: 1 (https://510kreport.com/company/navier-medical)

## Its most-cited devices
- K183012: vascuCAP (2018), cited by 1
- K163071: vascuCAP (2017), cited by 1
- K221463: ElucidVivo A.3 (2022), cited by 1

## Recent decisions
- K262015: Elucid FFR-IQ (B.1) (Sep 29, 2026)
- K261855: Elucid PlaqueIQ (Sep 18, 2026)
- K241524: Elucid PlaqueIQ (Sep 12, 2024)
- K221463: ElucidVivo A.3 (Jun 17, 2022)
- K183012: vascuCAP (Dec 21, 2018)
- K163071: vascuCAP (May 24, 2017)

Source page: https://510kreport.com/company/elucid-bioimaging